Kalaris Therapeutics, Inc. (KLRS) at a glance

Kalaris Therapeutics, Inc. (KLRS) is a micro-cap Healthcare company. It trades at $4.2, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 48/100 overall. Its strongest dimension is Value (58/100) and its weakest is Momentum (26/100).

Price
$4.20
Market cap
$103.0M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$2.50 to $11.88
Vestovix Score48/ 100How this works
Value
58
Growth
50
Income
40
Safety
52
Momentum
26

Other Healthcare stocks

See all